Filing Details

Accession Number:
0001209191-19-049680
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-09-16 17:26:06
Reporting Period:
2019-09-12
Accepted Time:
2019-09-16 17:26:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1770787 10X Genomics Inc. TXG () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1562157 Foresite Capital Fund I, L.p. 600 Montgomery Street
Suite 4500
San Francisco CA 94111
No No Yes No
1581219 Foresite Capital Management I, Llc 600 Montgomery Street
Suite 4500
San Francisco CA 94111
No No Yes No
1581754 B. James Tananbaum 600 Montgomery Street
Suite 4500
San Francisco CA 94111
No No Yes No
1594912 Foresite Capital Management Ii, Llc 600 Montgomery Street
Suite 4500
San Francisco CA 94111
No No Yes No
1594914 Foresite Capital Fund Ii, L.p. 600 Montgomery Street
Suite 4500
San Francisco CA 94111
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2019-09-12 187,500 $39.00 187,500 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class B Common Stock Series A-2 Convertible Preferred Stock Disposition 2019-09-16 5,487,470 $0.00 5,487,470 $0.00
Class B Common Stock Series B Convertible Preferred Stock Disposition 2019-09-16 1,002,166 $0.00 1,002,166 $0.00
Class B Common Stock Series C Convertible Preferred Stock Disposition 2019-09-16 558,260 $0.00 558,260 $0.00
Class B Common Stock Series B Convertible Preferred Stock Disposition 2019-09-16 5,513,058 $0.00 5,513,058 $0.00
Class B Common Stock Series C Convertible Preferred Stock Disposition 2019-09-16 1,324,195 $0.00 1,324,195 $0.00
Class A Common Stock Class B Common Stock Acquisiton 2019-09-16 7,047,896 $0.00 7,047,896 $0.00
Class A Common Stock Class B Common Stock Acquisiton 2019-09-16 6,837,253 $0.00 6,837,253 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
7,047,896 No 4 C Indirect
6,837,253 No 4 C Indirect
Footnotes
  1. FCF I purchased 187,500 shares of Issuer's Class A Common Stock in connection with the Issuer's initial public offering at the offering price of $39.00 per share.
  2. The shares are owned directly by Foresite Capital Fund I, L.P. ("FCF I"). Foresite Capital Management I, LLC ("FCM I"), the general partner of FCF I, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM I, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a "group." Each of FCM I and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM I and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose.
  3. Each share of Series A-2 Convertible Preferred Stock automatically converted, for no additional consideration, into one (1) share of Issuer's Class B Common Stock upon the closing of the Issuer's initial public offering.
  4. The Series A-2 Convertible Preferred Stock has no expiration date.
  5. Each share of Series B Convertible Preferred Stock automatically converted, for no additional consideration, into one (1) share of Issuer's Class B Common Stock upon the closing of the Issuer's initial public offering.
  6. The Series B Convertible Preferred Stock has no expiration date.
  7. Each share of Series C Convertible Preferred Stock automatically converted, for no additional consideration, into one (1) share of Issuer's Class B Common Stock upon the closing of the Issuer's initial public offering.
  8. The Series C Convertible Preferred Stock has no expiration date.
  9. The shares are owned directly by Foresite Capital Fund II, L.P. ("FCF II"). Foresite Capital Management II, LLC ("FCM II"), the general partner of FCF II, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM II, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a "group." Each of FCM II and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM II and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose.
  10. Each share of Class B Common Stock is convertible, for no additional consideration, into one (1) share of Class A Common Stock at any time at the holder's election.
  11. The Class B Common Stock has no expiration date.
  12. Each share of Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted, for no additional consideration, into one (1) share of Issuer's Class B Common Stock upon the closing of the Issuer's initial public offering.
  13. Each share of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted, for no additional consideration, into one (1) share of Issuer's Class B Common Stock upon the closing of the Issuer's initial public offering.